Red Cross Offers Warmth, Shelter as Storm Cuts Power Across t...(ecure online contribution by visiting ...),Health
Navigation Links
Red Cross Offers Warmth, Shelter as Storm Cuts Power Across the Country
Date:1/28/2009
ecure online contribution by visiting www.redcross.org.
'/>"/>
| SOURCE American Red Cross Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Breast cancer prevention practices vary across Canada
2. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
3. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time
4. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
5. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
6. Independence Blue Cross Makes Music for Members Ears
7. Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention
8. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
9. Harvard Researchers Select S.C. BlueCross for National Honor
10. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
11. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 2Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 3Health News:Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment 2Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 2Health News:AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives 3Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 2Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 3Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 4Health News:All-New TendoFlex(TM) Revolutionizes Stretching and Core Strengthening 2
[0] Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine[1] Bishops Deeply Disappointed by Senate Vote to Table Nelson-Hatch-Casey Amendment[1] AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives[0] Bone Marrow Transplants May Cure Sickle Cell in Adults [1] All-New TendoFlex(TM) Revolutionizes Stretching and Core Strengthening
Other Medicine News:Health News:Thermage and Reliant Technologies to Join Forces 2Health News:Thermage and Reliant Technologies to Join Forces 3Health News:Thermage and Reliant Technologies to Join Forces 4Health News:Thermage and Reliant Technologies to Join Forces 5Health News:Thermage and Reliant Technologies to Join Forces 6Health News:Thermage and Reliant Technologies to Join Forces 7Health News:Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product 2Health News:Couples with fertility problems where the man is over 35 have increased difficulty in conceiving 2Health News:Couples with fertility problems where the man is over 35 have increased difficulty in conceiving 3Health News:Food Allergens Show Up in Unexpected Places 2Health News:Dramatic Increase in 'Tommy John' Surgery in Young Patients Cause for Concern 2Health News:Dramatic Increase in 'Tommy John' Surgery in Young Patients Cause for Concern 3
Thermage and Reliant Technologies to Join ForcesLabopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol ProductCouples with fertility problems where the man is over 35 have increased difficulty in conceivingFood Allergens Show Up in Unexpected PlacesTopical oral syrup prevents early childhood cariesDramatic Increase in 'Tommy John' Surgery in Young Patients Cause for Concern
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Beckman Coulter Declares Quarterly Dividend Payout of 240 17 Per Share 13218 1VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 1VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 2Tight Management of Type 1 Diabetes Worth the Effort 52844 1Tight Management of Type 1 Diabetes Worth the Effort 52844 2Tight Management of Type 1 Diabetes Worth the Effort 52844 3
[0] Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals[0] Al Novak Elected Chairman of the Board of OrbusNeich Medical[0] National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards
Other Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |